DrugPatentWatch Database Preview
Details for Patent: 8,795,725
Which drugs does patent 8,795,725 protect, and when does it expire?
This patent has twenty-three patent family members in sixteen countries.
Summary for Patent: 8,795,725
Title: | GABA analog prodrug sustained release oral dosage forms |
Abstract: | Sustained release oral dosage forms of a gabapentin prodrug, 1-{[(.alpha.-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective. |
Inventor(s): | Cundy; Kenneth C. (Redwood City, CA), Sastry; Srikonda (Sunnyvale, CA), Leung; Manshiu (Daily City, CA), Kadri; Balaji V. (Tampa, FL), Stach; Paul E. (Plymouth, MN) |
Assignee: | XenoPort, Inc. (Santa Clara, CA) |
Application Number: | 11/269,045 |
Patent Claim Types: see list of patent claims | Compound; Dosage form; Composition; Use; |
Drugs Protected by US Patent 8,795,725
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | ➤ Try a Free Trial | |||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS | ➤ Try a Free Trial | |||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS | ➤ Try a Free Trial | |||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,795,725
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,906,412 | GABA analog prodrug sustained release oral dosage forms | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,795,725
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2005301970 | ➤ Try a Free Trial | |||
Brazil | PI0517227 | ➤ Try a Free Trial | |||
Canada | 2584338 | ➤ Try a Free Trial | |||
China | 101068538 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |